SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-035050
Filing Date
2019-06-12
Accepted
2019-06-12 16:14:46
Documents
2
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1447
2 EX-24 ex-24.htm EX-24 6252
  Complete submission text file 0001104659-19-035050.txt   9075
Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL, UNIT 325 CHARLOTTE NC 28277
Business Address
Schmidt Keith (Reporting) CIK: 0001389235 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37590 | Film No.: 19893730

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences